Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
naltrexone delta-type opioid receptor small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Maintenance[MeSHID:D008283]
Alcohol consumption[MeSHID:D000428]
emotional dependency[MeSHID:D003858]
Metabolic Detoxication
Drug[MeSHID:D008658]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Alcoholic Intoxication
Chronic[MeSHID:D000437]
Disease[MeSHID:D004194]		 1.47 approved,investigational,vet_approved antagonist
naltrexone delta-type opioid receptor small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Maintenance[MeSHID:D008283]
Alcohol consumption[MeSHID:D000428]
emotional dependency[MeSHID:D003858]
Metabolic Detoxication
Drug[MeSHID:D008658]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Alcoholic Intoxication
Chronic[MeSHID:D000437]
HIV Infections[MeSHID:D015658]		 1.47 approved,investigational,vet_approved antagonist
naltrexone kappa-type opioid receptor small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Maintenance[MeSHID:D008283]
Alcohol consumption[MeSHID:D000428]
emotional dependency[MeSHID:D003858]
Metabolic Detoxication
Drug[MeSHID:D008658]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Alcoholic Intoxication
Chronic[MeSHID:D000437]
HIV Infections[MeSHID:D015658]		 0.8 approved,investigational,vet_approved antagonist
naltrexone kappa-type opioid receptor small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Maintenance[MeSHID:D008283]
Alcohol consumption[MeSHID:D000428]
emotional dependency[MeSHID:D003858]
Metabolic Detoxication
Drug[MeSHID:D008658]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Alcoholic Intoxication
Chronic[MeSHID:D000437]
Disease[MeSHID:D004194]		 0.8 approved,investigational,vet_approved antagonist
naltrexone mu-type opioid receptor small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Maintenance[MeSHID:D008283]
Alcohol consumption[MeSHID:D000428]
emotional dependency[MeSHID:D003858]
Metabolic Detoxication
Drug[MeSHID:D008658]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Alcoholic Intoxication
Chronic[MeSHID:D000437]
Disease[MeSHID:D004194]		 1.35 approved,investigational,vet_approved antagonist
naltrexone mu-type opioid receptor small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Maintenance[MeSHID:D008283]
Alcohol consumption[MeSHID:D000428]
emotional dependency[MeSHID:D003858]
Metabolic Detoxication
Drug[MeSHID:D008658]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Alcoholic Intoxication
Chronic[MeSHID:D000437]
HIV Infections[MeSHID:D015658]		 1.35 approved,investigational,vet_approved antagonist
naltrexone hcg20471, isoform cra_c small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Maintenance[MeSHID:D008283]
Alcohol consumption[MeSHID:D000428]
emotional dependency[MeSHID:D003858]
Metabolic Detoxication
Drug[MeSHID:D008658]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Alcoholic Intoxication
Chronic[MeSHID:D000437]
HIV Infections[MeSHID:D015658]		 2.89 approved,investigational,vet_approved antagonist
naltrexone hcg20471, isoform cra_c small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Maintenance[MeSHID:D008283]
Alcohol consumption[MeSHID:D000428]
emotional dependency[MeSHID:D003858]
Metabolic Detoxication
Drug[MeSHID:D008658]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Alcoholic Intoxication
Chronic[MeSHID:D000437]
Disease[MeSHID:D004194]		 2.89 approved,investigational,vet_approved antagonist
click here to return to the previous page